Trial Profile
Clinical Trials Insight: 700057100
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Jun 2010
Price :
$35
*
At a glance
- Drugs Ibrigampar (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors InteKrin Therapeutics
- 21 Jun 2010 New trial record